Overview
Location
United States, Montana, Bozeman
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 10, 2026 | Alercell Appoints Ina Dreschnack, MSc, Harvard Researcher in Neuroscience and Translational Medicine to Advisory Board | Published molecular biologist in extracellular vesicle and stem cell therapeutics joins Alercell to inform translational research for LENA Platform™ and LENA-Rx Alercell represents a fundamental shift in how we view hematologic malignancy: ... |
| Jun 2, 2026 | Alercell Appoints Paul A. Dreschnack, MD, Harvard Surgeon and Four-Time Nobel Peace Prize Nominee, to Advisory Board | Microsurgeon and stemcell therapeutics pioneer joins Alercell to inform clinical translation of the LENA Platform for pre-symptomatic detection of blood cancers Alercell is doing something that shifts the frame for hematologic malignancy de... |
| May 27, 2026 | ALERCELL APPOINTS JASON YAGER TO ADVISORY BOARD TO LEAD MONTANA ECOSYSTEM AND WORKFORCE STRATEGY | Alercell Montana Photonics & Quantum Alliance Ex. Director joins precision oncology firm developing AI epigenetic platform for pre-symptomatic blood cancer detection Alercell is doing exactly the kind of work Montana needs more of: rigo... |
| Mar 23, 2026 | Alercell Unveils AI Cancer Detection Platform Validated on 199,000+ Patient Records | LENA Platform's four LDT products detect leukemia up to 41 months before symptoms — now live at alercell.com Alercell is proving that rigorous epigenetic science and AI validation make early detection both clinically superior and comme... |
| Apr 23, 2025 | Alercell to Deliver Lightning Pitch at Startup Grind Global Conference 2025 | Logo Frederic Scheer Joins Visionary Founders in a Fast-Paced Startup Showcase at Silicon Valley’s Fox Theatre This is more than a company showcase—it’s a call to action,” — Frederic ScheerBOZEMAN, MT, UNITED STATES, April 23, 2025 /EINPres... |
| Apr 9, 2025 | Alercell CEO Frederic Scheer to Speak at Startup Grind Global Conference 2025 | Alercell Alercell Exhibitor at Startup Grind Global Conference 2025 I am proud to represent Alercell at Startup Grind Global Conference 2025 in Silicon Valley” — Frederic ScheerBOZEMAN, MT, UNITED STATES, April 9, 2025 /EINPresswire.com/ --... |
| Jun 17, 2024 | Alercell Unveils Lena S1® Methylated Genes Diagnostic Test for Early Lung Cancer Detection | LENA S1® leverages the methylation technique, enabling the detection of lung cancer at a remarkably early stage The RUO Lena S1® test is a breakthrough aimed at enhancing patient care and guiding the selection of effective treatments for lu... |
| Feb 4, 2024 | Alercell Embraces Artificial Intelligence to Revolutionize Oncology Diagnostics on World Cancer Day | Alercell to use Artificial Intelligence to Revolutionize Oncology Diagnostics Alercell believe it's time to shift the paradigm in the pharma industry towards prevention. Incorporating AI into our R&D processes marks a significant s... |
| Feb 1, 2024 | ALERCELL ANNOUNCES THE LAUNCH OF LENA PAN-MPN qPCR PANEL | Alercell increase its Leukemia Testing Platform LENA PAN-MPC qPCR panel is a significant advancement in the field of leukemia. Our primary aim is to revolutionize patient care by facilitating early detection and precise therapeutic selectio... |
Show more
Reviews 0
FAQ about Alercell
What has the press written about Alercell?
Parsers VC has collected 12 articles mentioning Alercell, among them “Alercell Appoints Ina Dreschnack, MSc, Harvard Researcher in Neuroscience and Translational Medicine to Advisory Board” (Jun 10, 2026) and “Alercell Appoints Paul A. Dreschnack, MD, Harvard Surgeon and Four-Time Nobel Peace Prize Nominee, to Advisory Board” (Jun 2, 2026).
Is Alercell still active?
Alercell is probably closed: its latest activity on Parsers VC dates from Oct 27, 2026.